Association between Area under the Curve Estimated from Carboplatin Dose and Incidence of Severe Thrombocytopenia in Patients with Non-Hodgkin’s Lymphoma on DeVIC Therapy

BACKGROUND: The degrees of adverse effects with carboplatin (CBDCA) are influenced by interindividual differences in the area under the curve (AUC), whereas renal function is not considered in the CBDCA dose design for dexamethasone, etoposide, ifosfamide, and CBDCA (DeVIC) therapy. We conducted thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Umehara, Kengo, Takada, Shinya, Yama, Kaori, Yamagishi, Kayo, Ebata, Ko, Sakai, Toshiya, Kobayashi, Michiya, Sato, Hideki, Mino, Kozo, Fujimoto, Katsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505877/
https://www.ncbi.nlm.nih.gov/pubmed/37378925
http://dx.doi.org/10.31557/APJCP.2023.24.6.1963

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505877/
https://www.ncbi.nlm.nih.gov/pubmed/37378925
http://dx.doi.org/10.31557/APJCP.2023.24.6.1963

Ejemplares similares